Chloroquine and hydroxychloroquine are 4-aminoquinoline compounds that are commonly used in the prevention and treatment of malaria. Hydroxychloroquine is also frequently used in the treatment of rheumatologic diseases such as systemic lupus erythematosus and gained notoriety during the COVID-19 pandemic when it was used experimentally in the treatment of SARS-CoV-2 infection. As the use of these drugs is common and spans many indications, the interprofessional healthcare team should be aware of potential drug toxicities and how to manage them. This activity reviews the indications for use, mechanisms of action, pharmacokinetics, potential toxicities, and management of toxicities related to chloroquine and hydroxychloroquine. Furthermore, this activity will empower members of the interprofessional healthcare team to recognize, treat, and mitigate chloroquine and hydroxychloroquine toxicity in the patients they serve.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/19439
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.5 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Chemical Pathology, Forensic Pathology, General Pediatrics, General Surgery, Hospital Medicine, Infectious Disease, Internal Medicine, Pediatric Infectious Diseases, Pediatric Rheumatology, Rheumatology